Therapeutics: T cell receptor (TCR); CD1D

Cancer

INDICATION: T cell lymphoma

Mouse and patient sample studies suggest inhibiting TCR signaling with anti-CD1D antibodies or cyclosporine A

Read the full 198 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE